Cargando…
Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted?
Autores principales: | Fally, Markus, Mathioudakis, Alexander G., Wingfield Digby, James, Williamson, Paula R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608423/ https://www.ncbi.nlm.nih.gov/pubmed/34823009 http://dx.doi.org/10.1016/j.cmi.2021.11.017 |
Ejemplares similares
-
Core Outcome Set-STAndards for Development: The COS-STAD recommendations
por: Kirkham, Jamie J., et al.
Publicado: (2017) -
Core Outcome Set–STAndards for Reporting: The COS-STAR Statement
por: Kirkham, Jamie J., et al.
Publicado: (2016) -
Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement
por: Kirkham, Jamie J., et al.
Publicado: (2019) -
Development of core outcome sets for both research and care
por: Kearney, Anna, et al.
Publicado: (2023) -
Towards core outcome set (COS) development: a follow-up descriptive survey of outcomes in Cochrane reviews
por: Wuytack, Francesca, et al.
Publicado: (2015)